BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 6850508)

  • 1. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and patterns of muramidase containing cells in Hodgkin's disease, non-Hodgkin's lymphomas, and reactive hyperplasia.
    Ree HJ; Song JY; Leone LA; Crowley JP; Fanger H
    Hum Pathol; 1981 Jan; 12(1):49-59. PubMed ID: 6162773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hodgkin's nodular paragranuloma (nodular Hodgkin's disease, with lymphocytic predominance): apropos of 29 cases].
    Molina T; Diebold J
    Bull Cancer; 1987; 74(4):463-72. PubMed ID: 3663967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant lymphoma simulating lymph node toxoplasmosis.
    Miettinen M; Franssila K
    Histopathology; 1982 Mar; 6(2):129-40. PubMed ID: 7076137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of progressive transformation of germinal centers.
    Osborne BM; Butler JJ
    Am J Surg Pathol; 1984 Oct; 8(10):725-33. PubMed ID: 6496841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease.
    Regula DP; Hoppe RT; Weiss LM
    N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
    Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
    J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular).
    Hansmann ML; Zwingers T; Böske A; Löffler H; Lennert K
    J Cancer Res Clin Oncol; 1984; 108(3):321-30. PubMed ID: 6511805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
    De Jong D; Van Gorp J; Sie-Go D; Van Heerde P
    Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. So-called "Lennert's lymphoma": is it a clinicopathologic entity?
    Kim H; Nathwani BN; Rappaport H
    Cancer; 1980 Mar; 45(6):1379-99. PubMed ID: 6986978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma.
    Grossman DM; Hanson CA; Schnitzer B
    Am J Surg Pathol; 1991 Jul; 15(7):668-76. PubMed ID: 2058762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Hodgkin's lymphoma following Hodgkin's disease. A case report and immunohistochemical corroboration.
    Shimizu K; Hara K; Kunii A
    Am J Clin Pathol; 1986 Sep; 86(3):370-4. PubMed ID: 3529930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Florid progressive transformation of germinal centers. A syndrome affecting young men, without early progression to nodular lymphocyte predominance Hodgkin's disease.
    Ferry JA; Zukerberg LR; Harris NL
    Am J Surg Pathol; 1992 Mar; 16(3):252-8. PubMed ID: 1599017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinicopathological study of nodular lymphocyte predominance Hodgkin's disease].
    Deng F; Liu X; Tang W
    Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):239-41. PubMed ID: 11601211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
    Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
    Knowles DM; Halper JP; Jakobiec FA
    Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?
    Schmidt U; Metz KA; Leder LD
    Br J Haematol; 1995 Jun; 90(2):398-403. PubMed ID: 7794762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin staining of carbohydrates of haemic cells. III. The cells of Hodgkin's disease and other lymphomas.
    Collins RD; Jacobson W; Stoddart RW
    Histopathology; 1982 Sep; 6(5):601-16. PubMed ID: 6183188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.